化合物简介
Bazedoxifene is a third generation selective estrogen receptor modulator (SERM), developed by Pfizer following the completion of their takeover of Wyeth Pharmaceuticals. In late 2013, Pfizer received approval for bazedoxifene as part of the combination drug DUAVEE in the prevention (not treatment) of postmenopausal osteoporosis. Bazedoxfiene is the result of an exclusive research collaboration between Wyeth Pharmaceuticals and Ligand Pharmaceuticals.
基本信息
中文名称
1-[[4-[2-(氮杂环庚烷-1-基)乙氧基]苯基]甲基]-2-(4-羟基苯基)-3-甲基-吲哚-5-醇
英文名称
1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol
中文别名
巴多昔芬
英文别名
TSE-424、bazedoxifene、Conbriza、Bazedoxifeno
CAS号
198481-32-2
分子式
C30H34N2O3
分子量
470.603
精确质量
470.257
PSA
57.86
LOGP
6.2689
编号系统
UNII
Q16TT9C5BK
物化性质
密度
1.19g/cm3
沸点
694.4ºC at 760 mmHg
闪点
373.8ºC
折射率
1.622
蒸汽压
6.33E-20mmHg at 25°C
合成路线